Corpus ID: 29063488

Update in gastroenterology.

@article{Diculescu2011UpdateIG,
  title={Update in gastroenterology.},
  author={M. Diculescu and M. Andrei},
  journal={Maedica},
  year={2011},
  volume={6 2},
  pages={
          154
        }
}
Chronic viral hepatitis B and C are a significant cause of chronic liver disease worldwide and still represent a pathology difficult to treat. Drugs available for the treatment of chronic hepatitis B (CHB) include nucleoside analogues, nucleotide analogues and immunomodulatory agent. Lamivudine is the most commonly prescribed drug in CHB worldwide, but resistance to lamivudine occurs in 15-30% of patients during the first year of treatment. Telbivudine (an HBV specific L-nucleosid… Expand